Correlation Between Protalix Biotherapeutics and Cognition Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Cognition Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Cognition Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Cognition Therapeutics, you can compare the effects of market volatilities on Protalix Biotherapeutics and Cognition Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Cognition Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Cognition Therapeutics.
Diversification Opportunities for Protalix Biotherapeutics and Cognition Therapeutics
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Protalix and Cognition is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Cognition Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cognition Therapeutics and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Cognition Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cognition Therapeutics has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Cognition Therapeutics go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and Cognition Therapeutics
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.96 times more return on investment than Cognition Therapeutics. However, Protalix Biotherapeutics is 1.04 times less risky than Cognition Therapeutics. It trades about 0.33 of its potential returns per unit of risk. Cognition Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 113.00 in Protalix Biotherapeutics on August 29, 2024 and sell it today you would earn a total of 55.00 from holding Protalix Biotherapeutics or generate 48.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. Cognition Therapeutics
Performance |
| Timeline |
| Protalix Biotherapeutics |
| Cognition Therapeutics |
Protalix Biotherapeutics and Cognition Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and Cognition Therapeutics
The main advantage of trading using opposite Protalix Biotherapeutics and Cognition Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Cognition Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognition Therapeutics will offset losses from the drop in Cognition Therapeutics' long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
| Cognition Therapeutics vs. Eliem Therapeutics | Cognition Therapeutics vs. Scpharmaceuticals | Cognition Therapeutics vs. Milestone Pharmaceuticals | Cognition Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |